UIM3:F:F-UBS ETF SICAV - FTSE 100 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 88.71

Change

0.00 (0.00)%

Market Cap

USD 0.07B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.02 (-0.06%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.07 (+0.14%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.30 (-0.05%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.08 (+0.14%)

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.47B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.63 (-0.58%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.48 (-0.45%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.15 (-0.06%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

-0.04 (-0.47%)

USD 40.89B
0ZC:F Zscaler Inc

-5.50 (-2.70%)

USD 37.92B

ETFs Containing UIM3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.71% 50% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.71% 49% F 57% F
Trailing 12 Months  
Capital Gain 13.04% 52% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.04% 51% F 56% F
Trailing 5 Years  
Capital Gain 11.40% 42% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.40% 42% F 53% F
Average Annual (5 Year Horizon)  
Capital Gain 7.07% 61% D- 61% D-
Dividend Return 7.07% 59% D- 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.75% 58% F 85% B
Risk Adjusted Return 60.16% 67% D+ 75% C
Market Capitalization 0.07B 25% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.